Agilent (NYSE:A) initiated with Hold rating and $85 (11% upside) price target at Stifel.
Avantor (NYSE:AVTR) initiated with Hold rating and $16 (flat) price target at Stifel.
Bio-techne (NASDAQ:TECH) initiated with Bur rating and $235 (15% upside) price target at Stifel.
Bruker (NASDAQ:BRKR) initiated with Hold rating and $53 (8% upside) price target at Stifel.
Danaher (NYSE:DHR) initiated with Hold rating and $150 (10% upside) price target at Stifel.
Exact Sciences (NASDAQ:EXAS) initiated with Buy rating and $110 (39% upside) price target at Stifel. Shares up 2% premarket.
Genocea Biosciences (NASDAQ:GNCA) initiated with Outperform rating and $7 (217% upside) price target at SVB Leerink. Shares up 5% premarket.
Illumina (NASDAQ:ILMN) initiated with Buy rating and $345 (15% upside) price target at Stifel.
Mettler-Toledo (NYSE:MTD) initiated with Hold rating and $790 (11% upside) price target at Stifel.
NanoString Technologies (NASDAQ:NSTG) initiated with Buy rating and $28 (18% upside) price target at Stifel.
PerkinElmer (NYSE:PKI) initiated with Buy rating and $102 (16% upside) price target at Stifel.
QIAGEN (NYSE:QGEN) initiated with Hold rating and $33 (11% downside risk) price target at Stifel. Shares up 1% premarket.
Repligen (NASDAQ:RGEN) initiated with Buy rating and $105 (29% upside) price target at Stifel.
Waters (NYSE:WAT) initiated with Hold rating and $210 (2% downside risk) price target at Stifel.
Aurora Cannabis (NYSE:ACB) upgraded to Overweight with a C$5.85 (34% upside) price target at Cantor Fitzgerald. Shares down 13% premarket in U.S.
BioCryst Pharmaceuticals (NASDAQ:BCRX) upgraded to Buy with a $4 (152% upside) price target at BofA Merrill Lynch. Shares up 12% premarket.
Canopy Growth (NYSE:CGC) downgraded to Hold with a C$25 (19% upside) price target at Canaccord Genuity. Shares down 3% premarket in U.S.
Leap Therapeutics (NASDAQ:LPTX) downgraded to Market Perform at Raymond James. Shares down 3% premarket.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.